The latest price target for Sabra Health Care REIT (NASDAQ:SBRA) was reported by Citizens Capital Markets on February 21, 2025. The analyst firm set a price target for $20.00 expecting SBRA to rise to within 12 months (a possible 25.31% upside). 11 analyst firms have reported ratings in the last year.

The latest analyst rating for Sabra Health Care REIT (NASDAQ:SBRA) was provided by Citizens Capital Markets, and Sabra Health Care REIT reiterated their market outperform rating.

The last upgrade for Sabra Health Care REIT Inc happened on January 7, 2025 when JMP Securities raised their price target to $20. JMP Securities previously had a market perform for Sabra Health Care REIT Inc.

The last downgrade for Sabra Health Care REIT Inc happened on January 17, 2025 when Truist Securities changed their price target from $18 to $17 for Sabra Health Care REIT Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sabra Health Care REIT, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sabra Health Care REIT was filed on February 21, 2025 so you should expect the next rating to be made available sometime around February 21, 2026.

While ratings are subjective and will change, the latest Sabra Health Care REIT (SBRA) rating was a reiterated with a price target of $20.00 to $20.00. The current price Sabra Health Care REIT (SBRA) is trading at is $15.96, which is out of the analyst’s predicted range.